Welcome to the COPD Canada web site!

COPD Canada is an independently registered non-profit association that was established in 2005. The association’s primary mandate is to educate and assist Canadians who suffer from Chronic Obstructive Pulmonary Disease (COPD).

At its core, COPD Canada is a patient advocacy group whose members are people who live with the burden of COPD. The association is involved in providing patient education materials and services, in a variety of formats, using different delivery methodologies. We also develop, sponsor and produce quality-of-life seminars for patients and their families.

COPD Canada strives to heighten visibility and awareness of Chronic Obstructive Pulmonary Disease to the Canadian public at large. The group advocates an expanded use of diagnostic testing for all Canadians who currently smoke or have smoked.

With a focus on emphysema and chronic bronchitis, COPD Canada reviews and interprets the latest scientific and medical advances from worldwide sources. As a result of these activities up-to-date information is made available, in easy-to-understand language, for Canadians who suffer from COPD.

The scientific and medical information we monitor is also edited into digest format (The COPD Digest) and is distributed to select members of the Canadian medical profession as well as government agencies, NGOs and other healthcare personnel.

If you would like to become a member of COPD Canada please click on the Membership link in the sidebar. Membership is free-of-charge , however, it is restricted to patients with COPD or their caregivers. As a member you will be invited to participate in all COPD Canada events. You will also receive complimentary copies of our "Living with COPD" newsletter.

COPD Canada
555 Burnhamthorpe Road, Suite 306
Toronto, Ont. M9C 2Y3

Tel: 416 916-2476 ext. 104  Fax: 416 352-6199
Email: henry.copdcanada@gmail.com   URL: www.copdcanada.info

 
Supported by an unrestricted educational grant from AstraZeneca Canada Inc.

www.astrazeneca.ca

Follow us on Twitter : click image below